FRESENIUS KABI USA FDA Approval ANDA 206802

ANDA 206802

FRESENIUS KABI USA

FDA Drug Application

Application #206802

Application Sponsors

ANDA 206802FRESENIUS KABI USA

Marketing Status

Prescription001

Application Products

001INJECTABLE;INTRAVENOUSEQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)0PALONOSETRON HYDROCHLORIDEPALONOSETRON HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2018-09-19STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAP

CDER Filings

FRESENIUS KABI USA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 206802
            [companyName] => FRESENIUS KABI USA
            [docInserts] => ["",""]
            [products] => [{"drugName":"PALONOSETRON HYDROCHLORIDE","activeIngredients":"PALONOSETRON HYDROCHLORIDE","strength":"EQ 0.25MG BASE\/5ML (EQ 0.05MG BASE\/ML)","dosageForm":"INJECTABLE;INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"09\/19\/2018","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2018-09-19
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.